Business

Amgen's stock saw a significant increase of over 12% after revealing positive initial data on its innovative weight loss injection, MariTide. This announcement sparked concerns among investors regarding new competition in the rapidly expanding weight loss drug market. The news led to a decline in the stock prices of Novo Nordisk and Eli Lilly, key
0 Comments
“Roundball Rock,” composed by John Tesh, is considered one of the greatest theme songs for TV sports, particularly for National Basketball Association games on NBC. The nostalgic association that NBA fans have with this tune is unparalleled, as it brings back memories of an era defined by Michael Jordan's dominance, the Chicago Bulls' success, and
0 Comments
The Federal Trade Commission has taken a bold step in challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name drugs. These companies, including Novo Nordisk, AstraZeneca, Boehringer Ingelheim, and others, have been warned about improperly listed drug patents, particularly for medications related to Type 2 diabetes, asthma, and COPD. The practice
0 Comments
Walgreens recently announced its plans to partner directly with drugmakers to provide cell and gene therapies to patients in the United States. This initiative is part of a broader expansion of the company's specialty pharmacy services. The establishment of a new business unit dedicated to the specialty pharmacy segment, which includes AllianceRx as a subsidiary,
0 Comments
The recent approval of Wegovy for heart health in the U.S. has opened up coverage opportunities for more than 3 million people with Medicare, according to a recent analysis from KFF. This means that beneficiaries who are obese or overweight, have a history of heart disease, and are specifically prescribed the weekly injection to reduce
0 Comments
PepsiCo recently reported its quarterly earnings and revenue, exceeding analysts' expectations. However, the company faced challenges due to weaker U.S. demand caused by various factors such as Quaker Oats recalls and backlash to higher prices for its products. Despite the overall positive results, PepsiCo experienced a drop in its share price, reflecting investor concerns. Let's
0 Comments